The Role of Injectable Devices in Nonsurgical Facial Rejuvenation: Clinical Impressions and Recommendations

Abstract

Noninvasive and minimally invasive, nonsurgical facial soft-tissue augmentation procedures are becoming increasingly popular alternatives to traditional rhytidectomy. As the processes underlying facial aging are elucidated, new techniques addressing facial volume loss will be required. Nonsurgical face-lifts utilize combinations of injectable agents and devices, including botulinum toxin type A, hyaluronic acid derivatives, poly-L-lactic acid, and calcium hydroxylapatite. The agents chosen by the clinician depend on the type of defect and the facial area involved. Botulinum toxin type A is the most commonly used product in the correction of dynamic rhytides, whereas injectable devices are used to correct depressions in the nasolabial fold, orbital rim, cheeks, and oral commissure. This article will review the various devices available and provide insights gained during the